Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment For Acute Coronary Syndromes Trial

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2600 participants.

Also called NCT01959451

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 2,600 participants (enrolled count) (from the registry)
Sponsor
  • LMU Klinikum Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01959451
Other papers using this trial's data
  • Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial Lancet (London, England), 2017-10-14 DOI, PubMed 28855078

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Austria, Germany, Hungary, Poland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01959451. Randomized; no masking; primary purpose treatment. Start 2013-09 (registry gives no type); primary completion 2016-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment For Acute Coronary Syndromes Trial
Acronym
TROPICAL-ACS
Condition
Acute Coronary Syndrome
Intervention (Drug)
Prasugrel
Intervention (Drug)
Clopidogrel
Lead sponsor
LMU Klinikum (class: other)

Record details

Record id
cardio:ct-nct01959451
Content hash
6766ab2b9e8a844d4c78d63094bd8162a306634c9b0feb5216c5051b75b3a547